EP Wealth Advisors LLC acquired a new stake in Koninklijke Philips (NYSE:PHG – Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 6,270 shares of the technology company’s stock, valued at approximately $205,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Fairscale Capital LLC bought a new stake in shares of Koninklijke Philips during the 2nd quarter worth about $54,000. CWM LLC lifted its position in Koninklijke Philips by 21.9% during the second quarter. CWM LLC now owns 3,429 shares of the technology company’s stock worth $86,000 after acquiring an additional 616 shares during the last quarter. Eastern Bank bought a new stake in shares of Koninklijke Philips during the third quarter worth approximately $88,000. Blue Trust Inc. grew its position in shares of Koninklijke Philips by 902.7% in the second quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock valued at $93,000 after purchasing an additional 3,331 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new position in shares of Koninklijke Philips during the third quarter worth approximately $107,000. 13.67% of the stock is currently owned by institutional investors and hedge funds.
Koninklijke Philips Trading Up 0.6 %
Shares of PHG stock opened at $25.79 on Friday. The stock has a market cap of $24.24 billion, a P/E ratio of -61.40, a price-to-earnings-growth ratio of 0.93 and a beta of 0.76. Koninklijke Philips has a 1 year low of $19.55 and a 1 year high of $32.91. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60. The stock has a 50 day simple moving average of $28.13 and a 200 day simple moving average of $28.20.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on PHG
Koninklijke Philips Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- What is a Secondary Public Offering? What Investors Need to Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The Role Economic Reports Play in a Successful Investment Strategy
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 5 discounted opportunities for dividend growth investors
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Free Report).
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.